874472-98-7

Basic information

• Product Name: 3-BROMO-2-METHOXYBENZONITRILE
• Synonyms: 3-BROMO-2-METHOXYBENZONITRILE;3-Bromo-2-methoxybenzonitrile 97%;2-Bromo-6-cyanoanisole≥ 99.5% (GC)
• CAS NO: 874472-98-7
• Molecular Formula: C₈H₆BrNO
• Molecular Weight: 212.05
• Product Categories: Aromatic Nitriles;Building Blocks;C8 to C9;Chemical Synthesis;Cyanides/Nitriles;Nitrogen Compounds;Organic Building Blocks
• Mol File: 874472-98-7.mol
• Article Data: 3

Chemical Properties

• Melting Point: 75-78 °C
• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-BROMO-2-METHOXYBENZONITRILE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BROMO-2-METHOXYBENZONITRILE(874472-98-7)
• EPA Substance Registry System: 3-BROMO-2-METHOXYBENZONITRILE(874472-98-7)

Safety Data

• Hazard Codes: Xn
• Statements: 20/21/22
• Safety Statements: 36/37
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 874472-98-7(Hazardous Substances Data)

Usage

Chemical Properties

Colorless to tan crystalline solid

Upstream product

• 1122-85-6 phenyl cyanate 
• 74-88-4 methyl iodide 
• 611-20-1 salicylonitrile 
• 13073-28-4 3-bromo-2-hydroxybenzonitrile 

Downstream Products

• 874472-84-1 2-methoxy-3-(4, 4,5,5-tetramethyl-1,3, 2-dioxaborolan-2-yl)benzonitrile 
• 1202677-56-2 2-methoxy-3-pyridin-4-yl-benzonitrile 
• 1260021-80-4 3-bromo-N-hydroxy-2-(methyloxy)benzenecarboximidamide 
• 791136-88-4 3-bromo-2-methoxybenzamide 
• 1202677-57-3 2-hydroxy-3-pyridin-4-yl-benzonitrile 
• 1202677-58-4 trifluoromethanesulfonic acid 2-cyano-6-pyridin-4-yl-phenyl ester 
• 1202661-18-4 6-pyridin-4-yl-4'-(quinolin-2-ylmethoxy)-biphenyl-2-carbonitrile 
• 1301610-50-3 tert-butyl (1-(4-((3-cyano-2-methoxyphenyl)ethynyl)phenyl)cyclobutyl)carbamate 
• 877159-73-4 (+/-)-5-chloro-6-(3-cyano-2-methoxyphenyl)-1,2,3,4-tetrahydro-2,2,4,8-tetramethylquinoline 

Relevant articles and documents

TYK2 INHIBITORS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.

DI-SUBSTITUTED PHENYL COMPOUNDS

Di-substituted phenyl compounds which are inhibitors of phosphodiesterase 10 are described as are processes, pharmaceutical compositions, pharmaceutical preparations and pharmaceutical use of the compounds in the treatment of mammals, including human(s) f